PERCEPTIVE ADVISORS LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:35 pm Sale | 2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | PERCEPTIVE ADVISORS LLC | 2,191,425 3.800% | -1,092,358 (-33.27%) | Filing |
| 2022-02-14 5:33 pm Sale | 2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | PERCEPTIVE ADVISORS LLC | 3,283,783 5.900% | -409,733 (-11.09%) | Filing |
| 2021-02-16 3:30 pm Purchase | 2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | PERCEPTIVE ADVISORS LLC | 3,693,516 7.400% | 490,110 (+15.30%) | Filing |